Robert S. Fishel's most recent trade in Opko Health Inc was a trade of 30,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 24, 2021.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Opko Health Inc | Robert S. Fishel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2021 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
Opko Health Inc | Robert S. Fishel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.04 per share. | 25 Jan 2021 | 40,000 | 40,000 (0%) | 0% | 3.0 | 121,600 | Common Stock |
Opko Health Inc | Robert S. Fishel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2021 | 40,000 | 0 | - | - | Stock Option (Right to Buy) | |
Opko Health Inc | Robert S. Fishel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2021 | 20,000 | 0 | - | - | Stock Option (Right to Buy) | |
Opko Health Inc | Robert S. Fishel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.03 per share. | 25 Jan 2021 | 20,000 | 60,000 (0%) | 0% | 2.0 | 40,600 | Common Stock |